Skip to main content
. 2013 Oct 13;67(12):1267–1282. doi: 10.1111/ijcp.12322

Figure 2.

Figure 2

Effects on glycaemic parameters (LOCF). Changes in HbA1c (A) and FPG (B). LOCF, last observation carried forward; FPG, fasting plasma glucose; PBO, placebo; CANA, canagliflozin; LS, least squares; SE, standard error; CI, confidence interval. *p < 0.001